It has been reported that EGFR and Notch signaling pathways are the most unbalanced in GBM cell lines [198], the former because of its hyper-activation in several tumor cells [199,200], and the latter due to its effects on tumor progression [201,202]. The gene discussed is EGFR; the disease is glioblastoma.